Mathias Schmidt
15Patents
2h-index
28Co-inventors
54Inventor score
Filing activity: Feb 13, 1997 → Nov 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5942602A | Growth factor receptor antibodies | Chemistry; Metallurgy | 40 | Expired |
| US6129915A | Epidermal growth factor receptor antibodies | Chemistry; Metallurgy | 20 | Expired |
| US9856310B2 | UTI fusion proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US6268514A | Use of nitroethane derivatives as microbicides and specific nitroethane derivatives | Human Necessities | 1 | Expired |
| US10351618B2 | UTI fusion proteins | Emerging Cross-Sectional Technologies | 1 | Active |
| US7741488B2 | Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer | Human Necessities | 0 | Active |
| US7714136B2 | Tetrahydropyridothiophenes | Human Necessities | 0 | Active |
| US8273890B2 | Thiophene-imidazopyridines | Human Necessities | 0 | Active |
| US7714135B2 | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer | Human Necessities | 0 | Expired |
| US10653145B2 | Herbicidal compositions comprising active compounds from the group of the HPPD inhibitors, safeners and triazines | Human Necessities | 0 | Active |
| US7803945B2 | Tetrahydropyridothiophenes | Human Necessities | 0 | Active |
| US7714134B2 | Compounds and use of tetrahydropyridothiophenes | Human Necessities | 0 | Expired |
| US7763728B2 | Tetrahydropyridothiophenes | Human Necessities | 0 | Active |
| US7517986B2 | Tetrahydropyridothiophenes for use in the treatment of cancer | Human Necessities | 0 | Expired |
| US7723523B2 | Tetrahydropyridothiophenes | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.